Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Anatomic Pathology Market size is poised to grow from USD 38.48 billion in 2024 to USD 113.82 billion by 2037, reflecting a CAGR of more than 8.7% during the forecast period, from 2025 to 2037. Currently in 2025, the industry revenue of anatomic pathology is evaluated at USD 40.82 billion.
The growth of the market can primarily be attributed to the growing number of laboratory tests worldwide. For instance, every year over 7 billion clinical lab tests are performed in the United States.
Anatomic (or anatomical) pathology being the branch of medicine studies the effects of particular disease on the structure of body organs and tissues. Anatomic pathology identifies abnormalities and help to diagnose disease and manage treatment. Most of the anatomic pathology is to help identify and manage various types of tumors or cancers, but it is also helps to evaluate other conditions. With the recent advancements digital pathology as well as Artificial Intelligence (AI), the demand for anatomic pathology is on the rise amongst the healthcare service providers, which in turn, is expected to create massive revenue generation opportunities for the key players operating in the global anatomic pathology market during the forecast period. For instance, as per a survey conducted on the integration of artificial intelligence into diagnostic pathology practice, out of 487 respondents, 80 percent expected the integration in the upcoming 5 or 10 years, whereas 70% predicted that AI tools could increase diagnostic efficiency in future.
Anatomic Pathology Sector: Growth Drivers and Challenges
Growth Drivers
-
Growing Cancer Cases – Cancer cases are detected through anatomic pathology report. With the rising cases of cancer and need for biopsies to be performed, the market for anatomic pathology is expected to boost in the projected period. For instance, it was observed that approximately 19 million new cancer cases were registered worldwide in 2020.
-
Upsurge in the Number of Pathologists – According to reports, it was found that, in the United States there were 21 292 active pathologists in June 2019 compared 12 839 anatomical and clinical pathologists in 2017.
- Rising Prevalence of Chron’s disease – According to reports, every year 100 to 300 per 100,000 people suffer from Chron’s disease in North America and western Europe.
- Growing Number of People Suffering from Kidney Disease –total number of people suffering from kidney disease is 850 million worldwide in 2021.
Challenges
- High Expenditure Associated in Developing Anatomic Pathology
- Non-availability of Refurbished Anatomic Pathology Equipment
- Challenges in Transformation of Pathology Trends
Anatomic Pathology Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.7% |
|
Base Year Market Size (2024) |
USD 38.48 billion |
|
Forecast Year Market Size (2037) |
USD 113.82 billion |
|
Regional Scope |
|
Anatomic Pathology Segmentation
Type (Services, Consumables, Instruments); Subdivision (Histopathology, Cytopathology)
The global anatomic pathology market is segmented and analyzed for demand and supply by type into services, consumables, and instruments. Amongst these segments, the services segment held the largest share, backed by the growing number of breast cancers along with the surge in the number of biopsies done worldwide. For instance, over 17 720 biopsies were recommended and performed, in between January 2019 to September 2020 in the United States.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Subdivision |
|
|
By Product Type |
|
|
By Application |
|
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportAnatomic Pathology Industry - Regional Synopsis
Regionally, the global anatomic pathology market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America will hold the largest share of 38% by 2037, backed by presence of a strong healthcare network in the region, growing number of hospitals and diagnostic centers, as well as the rising demand for advanced anatomic pathology amongst the healthcare service providers owing to the rising number of surgeries in the region. For instance, it was observed that, 15 million Europeans have surgery every year. Some of the most common surgeries performed are appendectomy, breast biopsy, carotid endarterectomy, cholecystectomy, coronary artery bypass and others.
Companies Dominating the Anatomic Pathology Landscape
- PHC Holdings Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Indica Labs, Inc.
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Sakura Finetek USA, Inc.
- Cardinal Health, Inc.
- BioGenex
- NeoGenomics Laboratories, Inc.
- Agilent Technologies, Inc.
In the News
-
Epredia, - a subsidiary of PHC Holdings Corporation announced that its parent company has acquired anatomical pathology suppliers Laurypath and Microm Microtech France (MMFrance) to mark strategic expansion of Epredia’s presence in Europe.
-
Indica Labs, Inc., - with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics(iCAIRD), announced an agreement to collaborate on the development of an AI-based digital pathology solution. The pathology will assist the detection of cancer within lymph nodes from colorectal surgery cases.
Author Credits: Radhika Pawar
- Report ID: 4377
- Published Date: Mar 21, 2025
- Report Format: PDF, PPT
